<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=348185225613720&amp;ev=PageView&amp;noscript=1">
Pacbio_Case_Study_HeaderText.png
 
 
PacBio Sequel Case Study
Glioblastoma is a devastating disease due in part to its often late-stage diagnosis, rapid progression, and poor survival rates. This case
study looks at how GENEWIZ utilized the PacBio® Sequel™ long-read technology to help a customer improve detection of structural
variants within glioblastoma samples.


 
 
 
 
 
This Case Study discusses:
  • Generation of thousands of long-reads using PacBio Sequel Single Molecule Real Time (SMRT) technology
  • Generation of highly accurate consensus sequences
  • Identification of approximately 20,000 structural variants
  • Future applications

Download Case Study

To learn more about our Whole Genome Sequencing services including long-read technology, visit our Whole Genome Sequencing page.